The detailed analysis showed that the region of amplification comprising GOLPH3 is very narrow and does not extend to DROSHA. However, the frequency of GOLPH3 amplification in lung cancer observed previously (56%) corresponded well to the frequency of gains/amplifications of DROSHA observed in our study (42%). The gene discussed is GOLPH3; the disease is lung carcinoma.